Population-Based Home Care Services in Breast Cancer: Utilization and Costs
Nicole Mittmann(Western University), Craig C. Earle(Canadian Partnership Against Cancer), Natasha B. Leighl(Princess Margaret Cancer Centre), Ning Liu, Matthew C. Cheung(Simon Fraser University), J. Porter(Institute for Clinical Evaluative Sciences), William K. Evans(NHS Forth Valley), Maureen Trudeau(Trillium Health Centre), Katie N. Dainty(St. Michael's Hospital), Pierre K. Isogai(Sunnybrook Health Science Centre), Refik Saskin(Ontario Institute for Cancer Research), Jeffrey S. Hoch(St. Michael's Hospital)
Cited by 18
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
|Journal of Clinical Oncology|2009|1.5k
Part 4: Advanced Life Support
|Circulation|2015|1.4k
Trends in the Aggressiveness of Cancer Care Near the End of Life
|Journal of Clinical Oncology|2004|995